IRWD
IRWD
NASDAQ · Biotechnology

Ironwood Pharmaceuticals Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks
$3.54
+0.02 (+0.57%)
As of Jun 21, 10:16 PM ET ·
Analyst Consensus
Buy
10
Analysts
Moderate
Coverage
Buy 7 70%
Hold 3 30%
Sell 0 0%
Price Target
Analyst Price Target +1,360.5% upside
Low Target $40.79
Average Target $51.70
High Target $62.56
Current Price $3.54
Current
$3.54
Target
$51.70
$40.79 $51.70 avg $62.56
Scenario Analysis
Bear Case
$40.79
1,052.3%
Low target
Base Case
$51.70
+1,360.5%
Avg target
Bull Case
$62.56
+1,667.2%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$5.78
-38.8% from high
52-Week Low
$0.62
+471.0% from low
Target vs 52W High
$51.70
+794.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -45.7%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +189.8%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -7.8%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -65.2%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -32.8%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -45.0%